Angiogenesis of the endometrium

Obstetrics and Gynecology

Volumn 94, Issue 1, 1999, Pages 148-153

  Abulafia, Ovadia ^a,b   Sherer, David M ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUAL CYCLE; METRORRHAGIA; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION; UTERUS MYOMA;

CARCINOMA; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; LEIOMYOMA; LEVONORGESTREL; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0032982230     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00262-8     Document Type: Review

References (49)

1. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award lecture. Cancer Res. 46:1986;467-473.
2. Folkman J. Tumor angiogenesis. Adv Cancer Res. 43:1985;175-203.
3. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:1990;4-6.
4. Koblizek T.I., Weiss C., Yancopoulos G.D., Deutsch U., Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol. 8:1998;529-532.
5. Klagsburn M., D'Amore D. Regulation of angiogenesis. Annu Rev Physiol. 53:1991;217-239.
6. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature. 362:1993;841-844.
7. Kandel J., Bossy-Wetzel E., Radvanyi F., Klagsburn M., Folkman J., Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell. 66:1991;1095-1104.
8. Nguyen M., Watanabe H., Budson A.E., Richie J.P., Folkman J. Elevated levels of angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst. 85:1993;241-242.
9. Folkman J., Klagsburn M. Angiogenic factors. Science. 235:1987;442-447.
10. O'Reilly M.S., Holmgren L., Chen C.C., Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 2:1996;689-692.
11. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., et al. Endostatin An endogenous inhibitor of angiogenesis and tumor growth . Cell. 88:1997;277-285.
12. Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 146:1995;1029-1039.
13. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845.
14. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckins L., Gertsenstein M., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439.
15. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
16. D'Amato R.J., Loughnan M.S., Flynn E., Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A. 91:1994;4082-4085.
17. Rogers P.A., Abberton K.M., Susil B. Endothelial cell migratory signal produced by human endometrium during the menstrual cycle. Hum Reprod. 7:1992;1061-1066.
18. Au C.L., Rogers P.A. Immunohistochemical staining of von Willebrand factor in human endometrium during normal menstrual cycle. Hum Reprod. 8:1993;17-23.
19. Shwieki D., Itin A., Neufeld G., Gitay-Goren H., Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest. 91:1993;2235-2243.
20. Iruela-Arispe M.L., Porter P., Bornstein P., Sage E.H. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest. 97:1996;403-412.
21. Torry D.S., Torry R.J. Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am J Reprod Immunol. 37:1997;21-29.
22. Kooy J., Taylor N.H., Healy D.L., Rogers P.A. Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation. Hum Reprod. 11:1996;1067-1072.
23. Zhu P., Luo H.Z., Shi W.L., Wang J.D., Cheng J., Xu R.H., et al. Observation of the activity of factor VIII in the endometrium of women pre- and post-insertion of three types of IUDs. Contraception. 44:1991;367-384.
24. Rogers P.A., Au C.L., Affandi B. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum Reprod. 8:1993;1396-1404.
25. Subakir S.B., Hadisaputra W., Handoyo A.E., Affandi B. Endometrial angiogenic response in Norplant users. Hum Reprod. 11:1996;51-55.
26. Jikihara H., Terada N., Yamamoto R., Nishikawa Y., Tanizawa O., Matsumoto K., et al. Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by human endometrial cancer. Am J Obstet Gynecol. 167:1992;207-211.
27. Fujimoto J., Fujita H., Hosoda S., Okada H., Tanaka N.G. Effect of medroxyprogesterone acetate on secondary spreading of endometrial cancer. Invasion Metastasis. 9:1989;209-215.
28. Abulafia O., Triest W.E., Adcock J.T., Sherer D.M. The effect of medroxyprogesterone acetate on angiogenesis in complex endometrial hyperplasia. Gynecol Oncol. 72:1999;193-198.
29. Anania C.A., Stewart E.A., Quade B.J., Hill J.A., Nowak R.A. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding. Mol Hum Reprod. 3:1997;685-691.
30. Kruitwagen R.F., Poels L.G., Willemsen W.N., de Ronde I.J., Jap C., Rolland R. Endometrial epithelial cells in peritoneal fluid during the early follicular phase. Fertil Steril. 55:1991;297-303.
31. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1:1995;27-31.
32. Ramey J.W., Archer D.F. Peritoneal fluid Its relevance to the development of endometriosis . Fertil Steril. 60:1993;1-14.
33. Halme J., Becker S., Haskill S. Altered maturation and function of peritoneal macrophages Possible role in pathogenesis of endometriosis . Am J Obstet Gynecol. 156:1987;783-789.
34. Oosterlynck D.J., Meuleman C., Sobis H., Vandeputte M., Koninckx P.R. Angiogenic activity of peritoneal fluid from women with endometriosis. Fertil Steril. 59:1993;778-782.
35. McLaren J., Prentice A., Charnock-Jones D.S., Smith S.K. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod. 11:1996;220-223.
36. McLaren J., Prentice A., Charnock-Jones D.S., Millican S.A., Muller K.H., Sharkey A.M., et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest. 11:1996;482-489.
37. Taylor R.N., Ryan I.P., Moore E.S., Hornung D., Shifren J.L., Tseng J.F. Angiogenesis and macrophage activation in endometriosis. Ann N Y Acad Sci. 828:1997;194-207.
38. Khorram O., Taylor R.N., Ryan I.P., Schall T.J., Landers D.V. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol. 169:1993;1545-1549.
39. Shifren J.L., Tseng J.F., Zaloudek C.J., Ryan I.P., Meng Y.G., Ferrara N., et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis . J Clin Endocrinol Metab. 81:1996;3112-3118.
40. Abulafia O., Triest W.E., Sherer D.M., Hansen C.C., Ghezzi F. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol. 86:1995;479-485.
41. Ishiwata I., Ishiwata C., Soma M., Ono I., Nakaguchi T., Ishikawa H. Tumor angiogenic activity of gynecologic tumor cell lines on the chorioallantoic membrane. Gynecol Oncol. 29:1988;87-93.
42. Doldi N., Bassan M., Gulisano M., Broccoli V., Boncinelli E., Ferrari A. Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer. Gynecol Endocrinol. 10:1996;375-382.
43. Charnock-Jones D.S., Sharkey A.M., Rajput-Williams J., Burch D., Schofield J.P., Fountain S.A., et al. Identification and localization of alternatively spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod. 48:1993;1120-1128.
44. Presta M. Sex hormones modulate the synthesis of basic fibroblast growth factor in human endometrial adenocarcinoma cells Implications for the neovascularization of normal and neoplastic endometrium . J Cell Physiol. 137:1988;593-597.
45. Kirschner C.V., Alanis-Amezcua J.M., Martin V.G., Luna N., Morgan E., Yang J.J., et al. Angiogenesis factor in endometrial carcinoma A new prognostic indicator? Am J Obstet Gynecol. 174:1996;1879-1884.
46. Guidi A.J., Abu-Jawdeh G., Tognazzi K., Dvorak H.F., Brown L.F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer. 78:1996;454-460.
47. Kaku T., Kamura T., Kinukawa N., Kobayashi H., Sakai K., Tsuruchi N., et al. Angiogenesis in endometrial carcinoma. Cancer. 80:1997;741-747.
48. Sim B.K., O'Reilly M.S., Liang H., Fortier A.H., He W., Madsen J.W., et al. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res. 57:1997;1329-1334.
49. Kuiper R.A., Schellens J.H., Blijham G.H., Beijnen J.H., Voest E.E. Clinical research on antiangiogenic therapy. Pharmacol Res. 37:1998;1-16.